These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 36782321)

  • 1. Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery.
    Shaw G; Schaefer R; Schmidt HA; Madden A; Chang J; Mozalevskis A; Msimanga-Radebe B; Mangadan Konath N; Verster A; Baggaley R; Rodolph M; Macdonald V
    Harm Reduct J; 2023 Feb; 20(1):16. PubMed ID: 36782321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary: the value of PrEP for people who inject drugs.
    Coleman RL; McLean S
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21112. PubMed ID: 27760686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient and Provider Perspectives on a Novel, Low-Threshold HIV PrEP Program for People Who Inject Drugs Experiencing Homelessness.
    Bazzi AR; Shaw LC; Biello KB; Vahey S; Brody JK
    J Gen Intern Med; 2023 Mar; 38(4):913-921. PubMed ID: 35614171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Take services to the people": strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda.
    Kamusiime B; Beima-Sofie K; Chhun N; Nalumansi A; Nalukwago GK; Kasiita V; Twesige CC; Kansiime R; Muwonge TR; Kyambadde P; Kadama H; Mudiope P; Glick S; Lambdin B; Mujugira A; Heffron R
    Addict Sci Clin Pract; 2024 Feb; 19(1):13. PubMed ID: 38395940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an inner city HIV pre-exposure prophylaxis service tailored to the needs of people who inject drugs.
    Grimshaw C; Boyd L; Smith M; Estcourt CS; Metcalfe R
    HIV Med; 2021 Nov; 22(10):965-970. PubMed ID: 34585494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs.
    Ayon S; Jeneby F; Hamid F; Badhrus A; Abdulrahman T; Mburu G
    Reprod Health; 2019 May; 16(Suppl 1):59. PubMed ID: 31138238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missed opportunities for healthcare providers to discuss HIV preexposure prophylaxis with people who inject drugs.
    Vincent W; McFarland W
    Int J Drug Policy; 2022 Dec; 110():103873. PubMed ID: 36252292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'PrEP is not ready for our community, and our community is not ready for PrEP': pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response.
    Guise A; Albers ER; Strathdee SA
    Addiction; 2017 Apr; 112(4):572-578. PubMed ID: 27273843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical Providers and Harm Reduction Views on Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.
    Hershow RB; Gonzalez M; Costenbader E; Zule W; Golin C; Brinkley-Rubinstein L
    AIDS Educ Prev; 2019 Aug; 31(4):363-379. PubMed ID: 31361517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited Knowledge and Mixed Interest in Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.
    Bazzi AR; Biancarelli DL; Childs E; Drainoni ML; Edeza A; Salhaney P; Mimiaga MJ; Biello KB
    AIDS Patient Care STDS; 2018 Dec; 32(12):529-537. PubMed ID: 30311777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contingency Management and Pre-Exposure Prophylaxis Adherence Support Services (CoMPASS): A hybrid type 1 effectiveness-implementation study to promote HIV risk reduction among people who inject drugs.
    Sung ML; Viera A; Esserman D; Tong G; Davidson D; Aiudi S; Bailey GL; Buchanan AL; Buchelli M; Jenkins M; John B; Kolakowski J; Lame A; Murphy SM; Porter E; Simone L; Paris M; Rash CJ; Edelman EJ
    Contemp Clin Trials; 2023 Feb; 125():107037. PubMed ID: 36460267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M
    Martel-Laferrière V; Feaster DJ; Metsch LR; Schackman BR; Loignon C; Nosyk B; Tookes H; Behrends CN; Arruda N; Adigun O; Goyer ME; Kolber MA; Mary JF; Rodriguez AE; Yanez IG; Pan Y; Khemiri R; Gooden L; Sako A; Bruneau J
    Trials; 2022 Apr; 23(1):341. PubMed ID: 35461260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pre-exposure Prophylaxis (PrEP) Care Cascade in People Who Inject Drugs: A Systematic Review.
    Mistler CB; Copenhaver MM; Shrestha R
    AIDS Behav; 2021 May; 25(5):1490-1506. PubMed ID: 32749627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Awareness of and interest in oral pre-exposure prophylaxis (PrEP) for HIV prevention and interest in hypothetical forms of PrEP among people who inject drugs in rural West Virginia.
    Schneider KE; White RH; O'Rourke A; Kilkenny ME; Perdue M; Sherman SG; Grieb SM; Allen ST
    AIDS Care; 2021 Jun; 33(6):721-728. PubMed ID: 32951438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding Access to Oral Preexposure Prophylaxis for People Who Inject Drugs in Bayelsa and Niger States, Nigeria.
    Nishimoto L; Ikani P; Achanya J; Idowu A; Olisa AL; Walker CF; Gottlieb A; Akolo C
    Glob Health Sci Pract; 2023 Feb; 11(1):. PubMed ID: 36853631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Provider Implicit Bias in Prescribing HIV Pre-exposure Prophylaxis (PrEP) to People Who Inject Drugs.
    Dubov A; Krakower DS; Rockwood N; Montgomery S; Shoptaw S
    J Gen Intern Med; 2023 Oct; 38(13):2928-2935. PubMed ID: 36964426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives on pre-exposure prophylaxis for people who inject drugs in the context of an hiv outbreak: A qualitative study.
    Smith M; Elliott L; Hutchinson SJ; Metcalfe R; Flowers P; McAuley A
    Int J Drug Policy; 2021 Feb; 88():103033. PubMed ID: 33249313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.
    Biello KB; Bazzi AR; Mimiaga MJ; Biancarelli DL; Edeza A; Salhaney P; Childs E; Drainoni ML
    Harm Reduct J; 2018 Nov; 15(1):55. PubMed ID: 30419926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative inquiry into perceptions of HIV pre-exposure prophylaxis among people who inject drugs living with hepatitis C in Seattle, WA, USA.
    Barry MP; Austin EJ; Bhatraju EP; Glick SN; Stekler JD; Tung EL; Hansen RN; Williams EC; Gojic AJ; Pickering EI; Tsui JI
    Harm Reduct J; 2022 Nov; 19(1):121. PubMed ID: 36320005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services.
    Bartholomew TS; Plesons M; Serota DP; Alonso E; Metsch LR; Feaster DJ; Ucha J; Suarez E; Forrest DW; Chueng TA; Ciraldo K; Brooks J; Smith JD; Barocas JA; Tookes HE
    Addict Sci Clin Pract; 2024 Mar; 19(1):21. PubMed ID: 38528570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.